seed
Stage
1
Investors
About
Solvemed Group develops PuRe™ Pupillometer, a smartphone-based FDA Class I medical device that enables accurate and lighting-invariant pupillary size and reactivity testing integrated with hospital EMR systems without additional hardware.
Explore Solvemed Group's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.